• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类羧酸酯酶:CES1、CES2和CES3的最新进展

Human carboxylesterases: an update on CES1, CES2 and CES3.

作者信息

Sanghani Sonal P, Sanghani Paresh C, Schiel Marissa A, Bosron William F

机构信息

Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana, USA.

出版信息

Protein Pept Lett. 2009;16(10):1207-14. doi: 10.2174/092986609789071324.

DOI:10.2174/092986609789071324
PMID:19508181
Abstract

Carboxylesterases belong to Phase I group of drug metabolizing enzymes. They hydrolyze a variety of drug esters, amides, carbamates and similar structures. There are five 'carboxylesterase' genes listed in the Human Genome Organization database. In this review, we will focus on the CES1, CES2 and CES3 genes and their protein products that have been partially characterized. Several variants of these three CESs result from alternate splicing, single nucleotide polymorphisms and multiple copy variants. The three CESs, are largely localized to tissues that are major sites of drug metabolism like the mucosa of the gastrointestinal tract, lungs and liver but, they differ in tissue-specific expression. The amino acid alignment of the three CESs reveals important conserved catalytic and structural residues. There are interesting insertions and deletions that may affect enzymatic function as determined by homology modeling of CES3 using the CES1 three-dimensional structure. A comparison of the substrate specificity of CES1 versus CES2 reveals broad but distinct substrate preferences. There is little information on the substrate specificity of CES3 but it seems to have a lower catalytic efficiency than the other two CESs for selected substrates.

摘要

羧酸酯酶属于药物代谢酶的I相酶类。它们能水解多种药物酯、酰胺、氨基甲酸酯及类似结构。人类基因组组织数据库中列出了五个“羧酸酯酶”基因。在本综述中,我们将聚焦于已得到部分表征的CES1、CES2和CES3基因及其蛋白质产物。这三种羧酸酯酶的多个变体源于可变剪接、单核苷酸多态性和多拷贝变体。这三种羧酸酯酶主要定位于药物代谢的主要场所,如胃肠道黏膜、肺和肝脏等组织,但它们在组织特异性表达方面存在差异。这三种羧酸酯酶的氨基酸序列比对揭示了重要的保守催化和结构残基。通过使用CES1三维结构对CES3进行同源建模确定,存在一些可能影响酶功能的有趣插入和缺失。CES1与CES2底物特异性的比较揭示了广泛但不同的底物偏好。关于CES3底物特异性的信息很少,但对于选定的底物,它似乎比其他两种羧酸酯酶具有更低的催化效率。

相似文献

1
Human carboxylesterases: an update on CES1, CES2 and CES3.人类羧酸酯酶:CES1、CES2和CES3的最新进展
Protein Pept Lett. 2009;16(10):1207-14. doi: 10.2174/092986609789071324.
2
Hydrolysis of irinotecan and its oxidative metabolites, 7-ethyl-10-[4-N-(5-aminopentanoic acid)-1-piperidino] carbonyloxycamptothecin and 7-ethyl-10-[4-(1-piperidino)-1-amino]-carbonyloxycamptothecin, by human carboxylesterases CES1A1, CES2, and a newly expressed carboxylesterase isoenzyme, CES3.伊立替康及其氧化代谢产物7-乙基-10-[4-N-(5-氨基戊酸)-1-哌啶基]羰基氧喜树碱和7-乙基-10-[4-(1-哌啶基)-1-氨基]羰基氧喜树碱被人羧酸酯酶CES1A1、CES2以及一种新表达的羧酸酯酶同工酶CES3水解。
Drug Metab Dispos. 2004 May;32(5):505-11. doi: 10.1124/dmd.32.5.505.
3
Characterization of recombinant human carboxylesterases: fluorescein diacetate as a probe substrate for human carboxylesterase 2.重组人羧酸酯酶的特性:荧光素二乙酸酯作为人羧酸酯酶 2 的探针底物。
Drug Metab Dispos. 2011 Aug;39(8):1329-33. doi: 10.1124/dmd.111.039628. Epub 2011 May 3.
4
Mammalian carboxylesterase 3: comparative genomics and proteomics.哺乳动物羧酸酯酶3:比较基因组学与蛋白质组学
Genetica. 2010 Jul;138(7):695-708. doi: 10.1007/s10709-010-9438-z. Epub 2010 Apr 28.
5
Structure and catalytic properties of carboxylesterase isozymes involved in metabolic activation of prodrugs.参与前药代谢活化的羧酸酯酶同工酶的结构与催化特性。
Molecules. 2008 Feb 18;13(2):412-31. doi: 10.3390/molecules13020412.
6
Opossum carboxylesterases: sequences, phylogeny and evidence for CES gene duplication events predating the marsupial-eutherian common ancestor.负鼠羧酸酯酶:序列、系统发育以及有袋类与真兽类共同祖先之前的羧酸酯酶基因重复事件的证据
BMC Evol Biol. 2008 Feb 20;8:54. doi: 10.1186/1471-2148-8-54.
7
Difference in substrate specificity of carboxylesterase and arylacetamide deacetylase between dogs and humans.狗和人类羧酸酯酶和芳基乙酰胺脱乙酰酶的底物特异性差异。
Eur J Pharm Sci. 2018 Jan 1;111:167-176. doi: 10.1016/j.ejps.2017.09.040. Epub 2017 Sep 28.
8
Baboon carboxylesterases 1 and 2: sequences, structures and phylogenetic relationships with human and other primate carboxylesterases.狒狒羧酸酯酶1和2:与人类及其他灵长类动物羧酸酯酶的序列、结构及系统发育关系
J Med Primatol. 2009 Feb;38(1):27-38. doi: 10.1111/j.1600-0684.2008.00315.x.
9
Presence and inter-individual variability of carboxylesterases (CES1 and CES2) in human lung.人肺中羧酸酯酶(CES1 和 CES2)的存在和个体间变异性。
Biochem Pharmacol. 2018 Apr;150:64-71. doi: 10.1016/j.bcp.2018.01.028. Epub 2018 Feb 3.
10
A new class of mammalian carboxylesterase CES6.一种新型哺乳动物羧酸酯酶 CES6。
Comp Biochem Physiol Part D Genomics Proteomics. 2009 Sep;4(3):209-17. doi: 10.1016/j.cbd.2009.03.002.

引用本文的文献

1
Polysorbates degrading enzymes in biotherapeutics - a current status and future perspectives.生物治疗药物中的聚山梨酯降解酶——现状与未来展望
Front Bioeng Biotechnol. 2025 Jan 10;12:1490276. doi: 10.3389/fbioe.2024.1490276. eCollection 2024.
2
Intestinal human carboxylesterase 2 (CES2) expression rescues drug metabolism and most metabolic syndrome phenotypes in global Ces2 cluster knockout mice.肠道人羧酸酯酶2(CES2)的表达可挽救全球Ces2基因簇敲除小鼠的药物代谢及大多数代谢综合征表型。
Acta Pharmacol Sin. 2025 Mar;46(3):777-793. doi: 10.1038/s41401-024-01407-4. Epub 2024 Nov 4.
3
Regulation of Human Hydrolases and Its Implications in Pharmacokinetics and Pharmacodynamics.
人类水解酶的调控及其在药代动力学和药效学中的意义。
Drug Metab Dispos. 2024 Oct 16;52(11):1139-1151. doi: 10.1124/dmd.123.001609.
4
Transcriptomic Association Analysis of the Metabolic Mechanism of Sulfamethoxazole in Channel Catfish ().斑点叉尾鮰中磺胺甲恶唑代谢机制的转录组关联分析()。 (注:括号内原文似乎不完整)
Animals (Basel). 2024 Mar 30;14(7):1059. doi: 10.3390/ani14071059.
5
Pharmacogenetic study of CES1 gene and enalapril efficacy.载脂蛋白 E 基因多态性与冠心病的相关性研究
J Appl Genet. 2024 Sep;65(3):463-471. doi: 10.1007/s13353-024-00831-w. Epub 2024 Jan 23.
6
CES1-Triggered Liver-Specific Cargo Release of CRISPR/Cas9 Elements by Cationic Triadic Copolymeric Nanoparticles Targeting Gene Editing of PCSK9 for Hyperlipidemia Amelioration.阳离子三嵌段共聚物纳米粒通过 CES1 触发肝脏特异性货物释放 CRISPR/Cas9 元件,靶向 PCSK9 基因编辑改善高血脂症
Adv Sci (Weinh). 2023 Jul;10(19):e2300502. doi: 10.1002/advs.202300502. Epub 2023 Apr 21.
7
Insights into the Degradation of Polymer-Drug Conjugates by an Overexpressed Enzyme in Cancer Cells.癌细胞中过表达的酶对聚合物-药物偶联物的降解作用的深入了解。
J Med Chem. 2023 Feb 23;66(4):2761-2772. doi: 10.1021/acs.jmedchem.2c01781. Epub 2023 Feb 14.
8
Catalyst-free visible-light-induced condensation to synthesize bis(indolyl)methanes and biological activity evaluation of them as potent human carboxylesterase 2 inhibitors.无催化剂可见光诱导缩合反应合成双(吲哚基)甲烷及其作为强效人羧酸酯酶2抑制剂的生物活性评价
RSC Adv. 2019 Dec 3;9(68):40168-40175. doi: 10.1039/c9ra08593a. eCollection 2019 Dec 2.
9
Highly Sensitive "Off/On" EPR Probes to Monitor Enzymatic Activity.高灵敏度“开/关”EPR 探针用于监测酶活性。
Chemistry. 2022 Mar 22;28(17):e202104563. doi: 10.1002/chem.202104563. Epub 2022 Mar 3.
10
Gene expression correlates of advanced epigenetic age and psychopathology in postmortem cortical tissue.死后皮质组织中晚期表观遗传年龄与精神病理学的基因表达相关性
Neurobiol Stress. 2021 Jul 29;15:100371. doi: 10.1016/j.ynstr.2021.100371. eCollection 2021 Nov.